DE3781034D1 - Topische pharmazeutische zubereitung mit besserer durchdringungsfaehigkeit. - Google Patents

Topische pharmazeutische zubereitung mit besserer durchdringungsfaehigkeit.

Info

Publication number
DE3781034D1
DE3781034D1 DE8787304945T DE3781034T DE3781034D1 DE 3781034 D1 DE3781034 D1 DE 3781034D1 DE 8787304945 T DE8787304945 T DE 8787304945T DE 3781034 T DE3781034 T DE 3781034T DE 3781034 D1 DE3781034 D1 DE 3781034D1
Authority
DE
Germany
Prior art keywords
penetraphability
better
pharmaceutical preparation
topical pharmaceutical
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787304945T
Other languages
English (en)
Other versions
DE3781034T2 (de
Inventor
Gerald Bruce Kasting
Ronald Lee Smith
Ellen Rand Massaro
William Earl Snyder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of DE3781034D1 publication Critical patent/DE3781034D1/de
Application granted granted Critical
Publication of DE3781034T2 publication Critical patent/DE3781034T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE8787304945T 1986-06-13 1987-06-04 Topische pharmazeutische zubereitung mit besserer durchdringungsfaehigkeit. Expired - Fee Related DE3781034T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87424886A 1986-06-13 1986-06-13

Publications (2)

Publication Number Publication Date
DE3781034D1 true DE3781034D1 (de) 1992-09-17
DE3781034T2 DE3781034T2 (de) 1993-02-18

Family

ID=25363318

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787304945T Expired - Fee Related DE3781034T2 (de) 1986-06-13 1987-06-04 Topische pharmazeutische zubereitung mit besserer durchdringungsfaehigkeit.

Country Status (9)

Country Link
EP (1) EP0249397B1 (de)
JP (1) JP2562455B2 (de)
AU (1) AU593656B2 (de)
CA (1) CA1302269C (de)
DE (1) DE3781034T2 (de)
ES (1) ES2042564T3 (de)
FI (1) FI86598C (de)
IE (1) IE59793B1 (de)
PH (1) PH24005A (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723502A (en) * 1985-07-18 1998-03-03 Proctor; Peter H. Topical spin trap composition and method
US5714510A (en) * 1985-07-18 1998-02-03 Proctor; Peter H. Topical proxyl composition and method
US5714482A (en) * 1985-07-18 1998-02-03 Proctor; Peter H. Topical spin labels and method
US6150405A (en) * 1985-07-18 2000-11-21 Proctor; Peter H. Hair loss treatment with ascorbates
US5728714A (en) * 1985-07-18 1998-03-17 Proctor; Peter H. Method for treating hair loss using tempo
US5472687A (en) * 1985-07-18 1995-12-05 Proctor; Peter H. Topical pyridine N-oxides
US5470876A (en) * 1985-07-18 1995-11-28 Proctor; Peter H. Topical sod for treating hair loss
US5716947A (en) * 1985-07-18 1998-02-10 Proctor; Peter H. Topical doxyl composition and method
LU86548A1 (fr) * 1986-08-07 1988-03-02 Oreal Composition sous forme de gel pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de piperidino-pyrimidine
US4888354A (en) * 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
GB8801318D0 (en) * 1988-01-21 1988-02-17 Leo Pharm Prod Ltd Pharmaceutical preparations
AUPP310798A0 (en) * 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
WO2000072883A2 (en) * 1999-06-02 2000-12-07 Aviana Biopharm Pharmaceutical transdermal compositions
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
AU2001282064B2 (en) 2000-08-03 2007-02-01 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
JP4020607B2 (ja) 2001-09-10 2007-12-12 日本発条株式会社 ボールジョイントおよびその製造方法
SE0104421D0 (sv) * 2001-12-21 2001-12-21 Ponsus Pharma Ab New composition
PT1670433E (pt) 2003-10-10 2012-02-08 Ferring Bv Fórmula farmacológica transdérmica para a minimização de resíduos na pele
CA2586815A1 (en) 2004-11-29 2006-06-01 Ambria Dermatology Ab A composition comprising at least 3 different diols
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
DE102005051862B4 (de) 2005-10-25 2018-08-30 Beiersdorf Ag Emulsion enthaltend 1,2-Alkandiole, Emulgatoren und polare Ölkomponenten sowie deren Verwendung
CA2646667C (en) 2006-04-21 2014-03-11 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
CA2819859A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
JP7072346B2 (ja) * 2015-03-27 2022-05-20 大正製薬株式会社 ローション剤
WO2017061971A1 (en) * 2015-10-06 2017-04-13 Assos Ilaç Kimya Gida Ürünleri Üretim Ve Tic. A. Ş. Topical minoxidil composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139619A (en) * 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
EP0095813A3 (de) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Durchdringende topische pharmazeutische Präparate, die 9-(2-Hydroxyäthoxymethyl)-guanin enthalten
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids

Also Published As

Publication number Publication date
AU7418287A (en) 1987-12-17
IE871561L (en) 1987-12-13
FI86598C (fi) 1992-09-25
JP2562455B2 (ja) 1996-12-11
JPS6345212A (ja) 1988-02-26
EP0249397B1 (de) 1992-08-12
PH24005A (en) 1990-02-09
FI872630A (fi) 1987-12-14
AU593656B2 (en) 1990-02-15
DE3781034T2 (de) 1993-02-18
FI872630A0 (fi) 1987-06-12
EP0249397A3 (en) 1988-03-23
CA1302269C (en) 1992-06-02
EP0249397A2 (de) 1987-12-16
ES2042564T3 (es) 1993-12-16
IE59793B1 (en) 1994-04-06
FI86598B (fi) 1992-06-15

Similar Documents

Publication Publication Date Title
DE3781034T2 (de) Topische pharmazeutische zubereitung mit besserer durchdringungsfaehigkeit.
DE3688532D1 (de) Pharmazeutische darreichungsform mit verzoegerter abgabe.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DE3882848D1 (de) Kosmetikbasiszubereitung mit arzneimitteleigenschaften.
DE3778723D1 (de) Leicht absorbierbare pharmazeutische zubereitung.
NL194578B (nl) Farmaceutisch preparaat met cyclosporine.
ATE71837T1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
NO883591D0 (no) Dermal administreringsform.
NO873534D0 (no) Stabilt farmasoeytisk gelpreparat.
DE3768419D1 (de) Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
NO882653D0 (no) Doseringsform.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
DE68907177D1 (de) Dosierungsform.
DE3682960D1 (de) Pharmazeutische praeparate.
DE3576118D1 (de) Pharmazeutische praeparate.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
DE3861529D1 (de) Arzneizubereitung mit indomethacin.
FI874382A (fi) Farmaceutiska preparat.
DK336489D0 (da) Farmaceutisk praeparat
DE68915203T2 (de) Pharmazeutische Mischungen.
DK16489A (da) Immunstimulerende praeparat.
DE58905160D1 (de) Pharmazeutische zubereitung.
FI875616A0 (fi) Farmaceutiska blandningar.
IT8520591A0 (it) Formulazione farmaceutica.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee